Table 4 Demographic and clinical data of the study population.

From: Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis

Parameter

Patients

Healthy control

No. of participants

75

23

Sex (male:female)

40:35

11:12

Mean age (years)

40 ± 11

39 ± 13

Body mass index, BMI (kg/m2)

23.81 ± 3.05

22.98 ± 2.95

AST level (U/L)

46.19 ± 63.97 (n = 74)

ALT level (U/L)

56.53 ± 72.22 (n = 74)

Serum albumin (g/L)

42.40 ± 4.93 (n = 74)

Serum total cholesterol, TCHO (mg/L)

38.31 ± 9.12 (n = 69)

Serum triglyceride, TG (mg/L)

15.19 ± 9.67 (n = 69)

High-density lipoprotein, HDL (mmol/L)

1.30 ± 0.63 (n = 69)

Low-density lipoprotein, LDL (mmol/L)

2.40 ± 0.86 (n = 69)

  1. AST aspartate aminotransferase, ALT alanine aminotransferase.